Duchenne muscular dystrophy: current cell therapies-Reference-Cited by-同舟云学术

Duchenne muscular dystrophy: current cell therapies

Published:2015-05-18 Issue:4 Volume:8 Page:166-177
ISSN:1756-2864
Container-title:Therapeutic Advances in Neurological Disorders
language:en
Short-container-title:Ther Adv Neurol Disord

Author:

Sienkiewicz Dorota¹,Kulak Wojciech²,Okurowska-Zawada Bożena¹,Paszko-Patej Grażyna¹,Kawnik Katarzyna¹

Affiliation:

1. Department of Pediatric Rehabilitation Medical University, Bialystok, Poland

2. Department of Pediatric Rehabilitation, Medical University of Białystok, 15-274 Bialystok, 17 Waszyngtona street, Poland

Abstract

Duchenne muscular dystrophy is a genetically determined X-linked disease and the most common, progressive pediatric muscle disorder. For decades, research has been conducted to find an effective therapy. This review presents current therapeutic methods for Duchenne muscular dystrophy, based on scientific articles in English published mainly in the period 2000 to 2014. We used the PubMed database to identify and review the most important studies. An analysis of contemporary studies of stem cell therapy and the use of granulocyte colony-stimulating factor (G-CSF) in muscular dystrophy was performed.

Publisher

SAGE Publications

Subject

Clinical Neurology,Neurology,Pharmacology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1756285615586123

Reference89 articles.

1. Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery

2. Antisense Oligonucleotide-Mediated Exon Skipping for Duchenne Muscular Dystrophy: Progress and Challenges

3. Duchenne Muscular Dystrophy: Continuous Noninvasive Ventilatory Support Prolongs Survival

4. Neurodegenerative diseases and oxidative stress

5. Stem Cells: Their Definition, Classification and Sources

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hotspots and trends in satellite cell research in muscle regeneration: A bibliometric visualization and analysis from 2010 to 2023;Heliyon;2024-09

2. Mustn1 in Skeletal Muscle: A Novel Regulator?;Genes;2024-06-23

3. Chimeric Cell Therapies as a Novel Approach for Duchenne Muscular Dystrophy (DMD) and Muscle Regeneration;Biomolecules;2024-05-13

4. Amelioration of Morphological Pathology in Cardiac, Respiratory, and Skeletal Muscles Following Intraosseous Administration of Human Dystrophin Expressing Chimeric (DEC) Cells in Duchenne Muscular Dystrophy Model;Biomedicines;2024-03-06

5. Duchenne and Becker muscular dystrophy: Cellular mechanisms, image analysis, and computational models: A review;Cytoskeleton;2024-01-15